A TXNIP inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SKL1223

Item No. 42952

Technical Information
Formal Name
N-(furan-2-ylmethyl)-4-(3-phenyl-1,2,4-oxadiazol-5-yl)aniline
Molecular Formula
C19H15N3O2
Formula Weight
Purity
≥98%
A solid
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Slightly soluble: 0.1-1 mg/ml
SMILES
C1(NCC2=CC=CO2)=CC=C(C3=NC(C4=CC=CC=C4)=NO3)C=C1
InChi Code
InChI=1S/C19H15N3O2/c1-2-5-14(6-3-1)18-21-19(24-22-18)15-8-10-16(11-9-15)20-13-17-7-4-12-23-17/h1-12,20H,13H2
InChi Key
PWITXLYJAFNARC-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    SKL1223 is an inhibitor of thioredoxin-interacting protein (TXNIP).1 It inhibits TXNIP promoter activity in a reporter assay using INS-1 cells expressing human TXNIP (IC50 = 0.64 µM) and decreases the levels of TXNIP in the same cells in a concentration-dependent manner. SKL1223 (5 or 20 µM) induces glucagon secretion from TC-1 mouse lung cancer cells and decreases glucagon-induced glucose production in primary mouse hepatocytes. It decreases fasting blood levels of glucose, serum levels of glucagon and triglycerides, and hepatic levels of triglycerides in mice when administered at a dose of 70 mg/kg per day. SKL1223 decreases blood levels of glucose and serum levels of glucagon in db/db mice but not in Txnip-/- mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wang, X., Luo, Z., Han, J., et al. Orally available small molecule regulates TXNIP expression and glucagon action for the treatment of diabetes. Research Square (2024).